RESEARCH TRIANGLE PARK, N.C., Jan. 9 QuintilesTransnational Corp. today announced the appointment of Kelly McKee, M.D., asExecutive Director of Operations for the company's Public Health andGovernment Services unit. McKee brings tremendous experience and expertise ininfectious diseases and vaccine product development. He will report to OrenCohen, M.D., Quintiles' Chief Medical and Scientific Officer, and Head of thePublic Health and Government Services unit.
"Kelly will play an important alliance management role with government andcommercial sponsors as well as Quintiles internal resources," Cohen said."Our team is resourced and committed to assisting pharmaceutical and biotechcompanies win government contracts to advance public health."
Prior to his appointment as Executive Director of Operations, McKee servedas Senior Director, Medical and Scientific Services (Infectious Diseases) forQuintiles where he was responsible for providing medical support toinvestigative sites. Previously, he served as Senior Director for ClinicalResearch for DynPort Vaccine Company where he directed clinical trials.
McKee earned his medical degree from the University of Virginia School ofMedicine and completed his internship, residency and fellowship training inpediatrics and pediatric infectious diseases at Vanderbilt UniversityHospital. He completed a 20-year career in the U.S. Army Medical Department,during which he completed residency training in Preventive Medicine at theWalter Reed Army Institute of Research. McKee also earned a Master's degreein Public Health from Johns Hopkins University School of Hygiene and PublicHealth.
About Quintiles Public Health and Government Services
Quintiles Public Health and Government Services has the expertise andexperience to develop products that improve global public health and enhancereadiness to respond to bioterrorism threats, through its partnerships withgovernments, non-governmental organizations (NGOs) and the biopharmaceuticalindustry.
Quintiles Transnational Corp. is powering the next generation ofhealthcare by providing a broad range of professional services in drugdevelopment, financial partnering and commercialization for the biotechnologyand healthcare industries. With about 20,000 employees and offices in morethan 50 countries, it is focused on providing customer-centric solutions thatare the gold standard of the industry. For more information, please visit thecompany's Web site at www.quintiles.com.
SOURCE Quintiles Transnational Corp.